Expanding access to naloxone, sterile syringes, and HIV preexposure prophylaxis can help prevent negative consequences of drug use and reduce inequities in overdose-related morbidity and mortality.
This agent recently achieved an additional indication to reduce myocardial infarction, stroke, coronary revascularization, and cardiovascular death risk in adult patients with ASCVD.